What Is Site Rotation?
Category: Dosing
The practice of alternating injection locations to prevent tissue damage, lipohypertrophy (fatty lumps), and ensure consistent absorption.
Detailed Explanation
Site rotation is the practice of systematically alternating injection locations when administering subcutaneous injections. The primary purpose is to prevent lipohypertrophy - the development of abnormal fatty lumps under the skin caused by repeated insulin or peptide injections in the same spot. These lumps can affect absorption rates and lead to inconsistent dosing. Regular site rotation also reduces the risk of scar tissue formation and maintains skin health.
Practical Context
Maintain at least 3-4 different injection sites and rotate between them systematically. Common rotation areas include the left and right sides of the stomach (avoiding 2 inches around the navel), the front of both thighs, and the back of both upper arms. Keep at least 1 inch between injection points within each area. For healing peptides like BPC-157, site rotation may be modified to keep injections near the injury area while still varying the exact point.
Frequently Asked Questions
How many injection sites should I rotate between?
Maintain at least 3-4 different sites. Many researchers use a systematic rotation between left stomach, right stomach, left thigh, and right thigh.
Related Peptides
- BPC-157 - A pentadecapeptide derived from human gastric juice, known for tissue healing properties. (Dosage | Calculator)
Related Terms
- Subcutaneous Injection - An injection into the fatty tissue layer just beneath the skin. The most common administration method for peptides, typically using a 29-31 gauge insulin syringe at a 45-90 degree angle.
- Insulin Syringe - A syringe calibrated in 'units' (typically 100 units = 1ml) used for subcutaneous injections. Available in 0.3ml, 0.5ml, and 1ml sizes with 29-31 gauge needles.
- Bioavailability - The proportion of a substance that enters the bloodstream and is available to produce an active effect. Subcutaneous injection provides near-complete bioavailability for most peptides.